Display options
Share it on

Mol Genet Genomic Med. 2014 Nov;2(6):504-11. doi: 10.1002/mgg3.98. Epub 2014 Jul 30.

Ten new ATM alterations in Polish patients with ataxia-telangiectasia.

Molecular genetics & genomic medicine

Marta Joanna Podralska, Agnieszka Stembalska, Ryszard Ślęzak, Aleksandra Lewandowicz-Uszyńska, Barbara Pietrucha, Sylwia Kołtan, Jadwiga Wigowska-Sowińska, Jacek Pilch, Maria Mosor, Iwona Ziółkowska-Suchanek, Agnieszka Dzikiewicz-Krawczyk, Ryszard Słomski

Affiliations

  1. Institute of Human Genetics of the Polish Academy of Sciences Pozna?, Poland.
  2. Department of Genetics, Wroclaw Medical University Wroclaw, Poland.
  3. 3rd Department and Clinic of Paediatrics, Immunology and Rheumatology of Developmental Age, Wroclaw Medical University Wroclaw, Poland.
  4. Department of Immunology, The Children's Memorial Health Institute Warsaw, Poland.
  5. Department of Pediatrics, Hematology and Oncology, Institute of Pediatrics, Medical Academy Bydgoszcz, Poland.
  6. Department of Developmental Neurology, University of Medical Sciences Pozna?, Poland.
  7. Department of Child Neurology, Medical University of Silesia Katowice, Poland.

PMID: 25614872 PMCID: PMC4303220 DOI: 10.1002/mgg3.98

Abstract

Inherited biallelic mutations of the ATM gene are responsible for the development of ataxia telangiectasia (AT). The objective of the present study was to conduct molecular analysis of the ATM gene in a cohort of 24 Polish patients with ataxia-telangiectasia with aim being to provide an updated mutational spectrum in Polish AT patients. As a result of molecular analysis, the status of recurrent mutation was confirmed and ten new ATM variants were detected. Application of MLPA analysis allowed the detection of large genomic deletion. Previously, this type of mutation had never been seen in our population. Finally, in silico analysis was carried out for newly detected ATM alterations. In addition, functional analysis was performed to evaluate the effects of intronic variants: c.3402+30_3402+32delATC.

Keywords: ATM; Ataxia telangiectasia; MLPA; Polish population; mutation analysis; sequencing

References

  1. Br J Cancer. 2012 Jan 17;106(2):262-8 - PubMed
  2. Hum Mutat. 2005 Jun;25(6):593 - PubMed
  3. Hum Mutat. 2003 Jul;22(1):43-50 - PubMed
  4. Am J Med Genet A. 2004 Apr 1;126A(1):33-40 - PubMed
  5. Am J Med Genet. 2000 May 29;92(3):170-7 - PubMed
  6. Hum Mutat. 2012 Jan;33(1):198-208 - PubMed
  7. Clin Exp Immunol. 2008 Aug;153(2):214-20 - PubMed
  8. FEBS Lett. 2010 Sep 10;584(17):3675-81 - PubMed
  9. DNA Repair (Amst). 2013 Aug;12(8):605-11 - PubMed
  10. Am J Hum Genet. 1996 Jul;59(1):40-4 - PubMed
  11. Hum Mutat. 1998;12(5):330-7 - PubMed
  12. Neurogenetics. 2011 Nov;12(4):273-82 - PubMed
  13. FASEB J. 2011 Nov;25(11):3849-60 - PubMed
  14. J Exp Med. 2004 Nov 1;200(9):1111-21 - PubMed
  15. Hum Mol Genet. 1999 Jan;8(1):69-79 - PubMed
  16. Ann Neurol. 2004 Jun;55(6):891-5 - PubMed
  17. Hum Mutat. 2005 Feb;25(2):118-24 - PubMed
  18. EMBO Rep. 2004 Aug;5(8):772-6 - PubMed
  19. Br J Cancer. 2011 Aug 9;105(4):586-91 - PubMed
  20. Ann Hum Genet. 2005 Nov;69(Pt 6):657-64 - PubMed
  21. Am J Hum Genet. 1999 Jun;64(6):1617-31 - PubMed
  22. Hum Mutat. 2003 Feb;21(2):123-31 - PubMed
  23. Am J Hum Genet. 1998 Jan;62(1):86-97 - PubMed
  24. Hum Mutat. 1999;14(2):156-62 - PubMed
  25. Hum Genet. 2005 Jul;117(2-3):101-6 - PubMed
  26. Ann Hum Genet. 2008 Jan;72(Pt 1):10-8 - PubMed
  27. Neuromolecular Med. 2013 Sep;15(3):536-40 - PubMed
  28. Am J Hum Genet. 1996 Aug;59(2):320-30 - PubMed

Publication Types